Sanner Completes Gilero Rebranding, Expands Chicago Innovation Facility
- Sanner unified its North American operations under a single brand following its 2024 acquisition of Gilero, consolidating medical device development, engineering, and pharmaceutical packaging expertise.
- The company expanded its Chicago facility with human factors laboratory, 3D printing, prototyping capabilities, and partnership access to mHUB Innovation Center to accelerate product development.
Operational Impact
The Chicago facility expansion adds dedicated human factors and rapid-prototyping capacity in a major medtech hub, enabling Sanner to reduce technology-transfer risk and accelerate time-to-market for device and pharmaceutical packaging customers.
Source: Contract Pharma Breaking News RSS
Cellares Partners with Seoul National University Hospital on Automated Cell Therapy Manufacturing
- Cellares will transfer SNUH's gene-modified hematopoietic stem cell therapy manufacturing process to its Cell Shuttle automated platform, including electroporation workflows.
- The proof-of-concept collaboration supports preclinical development and IND-enabling manufacturing for SNUH's paroxysmal nocturnal hemoglobinuria program ahead of U.S. clinical trials.
- Partnership marks Cellares' second Asia collaboration and expands its APAC footprint while addressing scalability and manufacturing reliability challenges in cell therapy production.
Operational Impact
Cellares' Seoul partnership validates its Cell Shuttle platform for complex autologous cell therapy workflows and establishes a second APAC manufacturing reference that may accelerate adoption among other sponsors preparing gene-modified HSPC programs for clinical translation.
Source: Contract Pharma Breaking News RSS